Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. Mar31Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
    Register
  2. Apr14Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    Register

For Bladder Cancer

  1. May 5Update on the Treatment of Bladder Cancer
    Part I of Living with Bladder CancerRegister

For Brain Cancer

  1. Mar18Update on Glioblastoma in Adults
    Register

For Colorectal Cancer

  1. Mar 8Advances in the Treatment of Colorectal Cancer
    Register

For Endometrial Cancer

  1. Mar23Update on the Treatment of Endometrial Cancer
    Register

For Gastric Cancer

  1. Mar29Advances in the Treatment of Gastric Cancer
    Register

For Head and Neck Cancer

  1. Apr28Treatment Update in Oral and Head and Neck Cancer
    Register

For Kidney Cancer

  1. Apr 9Advances in the Treatment of Renal Cell Cancer
    Register

For Leukemia

  1. Mar25Update on Chronic Lymphocytic Leukemia (CLL)
    Part I of Living with Chronic Lymphocytic Leukemia (CLL)Register
  2. Apr 8Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)
    Part II of Living with Chronic Lymphocytic Leukemia (CLL)Register

For Lung Cancer

  1. Apr 6Update on Small Cell Lung Cancer Treatments
    Register

For Lymphoma

  1. Mar22Progress in the Treatment of Follicular Lymphoma
    Register

For Mantle Cell Lymphoma

  1. Mar30Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    Register
  2. Apr15Treatment Update on Mantle Cell Lymphoma (MCL)
    Part I of Living with Mantle Cell LymphomaRegister
  3. Apr21Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    Register
  4. May10Update on CAR T Cell Therapy
    Register
  5. May13Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    Register

Past workshops

For All Cancers

    1. Cancer and Flu Shots
    2. Treatment Adherence: Taking Your Pills on Schedule – Why It Is So Important
    3. What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    4. Managing the Side Effects of Immunotherapy
      Part II of New Trends in Immunotherapy
    5. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of New Trends in Immunotherapy
    6. Participating in Decisions about Your Care
      Part IV of Life with Cancer: A Guide to Getting the Best Care
    7. Understanding the Costs of Care and Your Health Care Coverage
      Part II of Life with Cancer: A Guide to Getting the Best Care
    8. Taking Your Treatment on Schedule: Its Importance in Managing Cancer
    9. Care for Your Bones During & After Cancer Treatment: Tips to Improve Bone Health
    10. Participating in Decisions about Your Care
      Part V of Life with Cancer: A Guide to Getting the Best Care
    11. Update on Clinical Trials: How They Work
    12. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising Approach to Treating Cancer
    13. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising Approach to Treating Cancer
    14. Taking Your Pills on Schedule: Its Importance in Treating Cancer
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Genomics and the Future of Cancer Treatment
    17. Genomics and Genetics: What is the Difference?
    18. What Are Biosimilars? Understanding Their Role in Cancer Treatments: Current and Future Perspectives
    19. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising New Approach to Treating Cancer
    20. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising New Approach to Treating Cancer
    21. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    22. What Are Generic Drugs: Understanding Their Role in Cancer Treatment
    23. Taking Your Pills on Schedule: The Importance of Adherence in the Treatment of Cancer
    24. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising New Approach to Treating Cancer
    25. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising New Approach to Treating Cancer
    26. What Are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    27. Taking Your Pills on Schedule – Why It Is So Important in Managing Cancer
    28. Understanding the Important Role of Adherence in the Medical Management of Cancer
    29. Medical Emergencies in Cancer Treatment

For Acute Lymphoblastic Leukemia

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on CAR-T Cell Therapy
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    8. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    9. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    10. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    11. Update on CAR-T Cell Therapy
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Acute Myeloid Leukemia

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Living with Acute Myelogenous Leukemia (AML)
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Updates in the Treatment of Acute Myelogenous Leukemia
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Medical Update on Acute Myelogenous Leukemia (AML)
    10. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    11. Update on CAR-T Cell Therapy
    12. Medical Update on Acute Myelogenous Leukemia (AML)
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Bladder Cancer

    1. What’s New in the Treatment of Bladder Cancer
      Part I of Life with Bladder Cancer
    2. Updates on the Treatment of Bladder Cancer
    3. Update on the Treatment of Bladder Cancer
      Part I of Living with Bladder Cancer

For Brain Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    2. Update on Glioblastoma in Adults
    3. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Breast Cancer

    1. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    2. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Triple Negative Breast Cancer and African American Women
    6. What’s New in the Treatment of Breast Cancer for Women of All Ages
    7. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. The Latest Developments Reported at the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    9. What’s New in the Treatment of Metastatic Breast Cancer
    10. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    11. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    12. The Latest Developments Reported at the 41st Annual San Antonio Breast Cancer Symposium (SABCS)
    13. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    14. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer
      Part II of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    15. The Latest Developments Reported at the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    16. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    17. Advances in the Treatment of HER2 Positive Breast Cancer
    18. El cáncer de seno y las mujeres hispanas (Breast Cancer and Hispanic Women)

For Chronic Lymphocytic Leukemia

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on CAR-T Cell Therapy
    3. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    6. Taking Your Blood Cancer Treatment on Schedule
    7. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia
    10. Update on Chronic Lymphocytic Leukemia
      Part I of Living with Chronic Lymphocytic Leukemia
    11. Update on Chronic Lymphocytic Leukemia (CLL) from the 2018 American Society of Hematology (ASH) Annual Meeting
    12. Update on Chronic Lymphocytic Leukemia (CLL)
    13. Older Persons Living with Chronic Lymphocytic Leukemia
    14. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    15. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    16. Managing Chronic Lymphocytic Leukemia and Its Complications
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    17. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    18. Update on CAR-T Cell Therapy
    19. Update on Chronic Lymphocytic Leukemia (CLL)
    20. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    21. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Chronic Myelogenous Leukemia

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Living with Chronic Myelogenous Leukemia (CML)
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    9. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    10. Update on CAR-T Cell Therapy
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Colorectal Cancer

    1. Progress in the Treatment of Colorectal Cancer
    2. Advances in the Treatment of Colorectal Cancer
    3. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    4. Update on the Treatment of Colorectal Cancer

For Cutaneous T-Cell Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on CAR-T Cell Therapy
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Update on Cutaneous T-Cell Lymphoma
    8. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    11. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Update on Cutaneous T-Cell Lymphoma
    15. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Advances in Immunotherapy in the Treatment of Lymphoma

For Diffuse Large B-Cell Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Update on Diffuse Large B-Cell Lymphoma
    7. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Update on Diffuse Large B-Cell Lymphoma
    11. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    12. Update on CAR-T Cell Therapy

For Follicular Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on CAR-T Cell Therapy
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Follicular Lymphoma
    8. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    9. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    10. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    11. Update on CAR-T Cell Therapy
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Progress in the Treatment of Follicular Lymphoma
    14. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Advances in Immunotherapy in the Treatment of Lymphoma

For Gastric Cancer

    1. Advances in the Treatment of Gastric Cancer
    2. Current Perspectives in the Treatment of Metastatic Gastric Cancer
    3. Advances in the Treatment of Gastric Cancer

For Gastrointestinal Stromal Tumors

    1. Advances in the Treatment of Gastrointestinal Stromal Tumors (GIST)
    2. Living with Gastrointestinal Stromal Tumors (GIST)

For Glioblastoma

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    2. Update on Glioblastoma in Adults
    3. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Head and Neck Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    2. What’s New in the Treatment of Oral and Head and Neck Cancer
    3. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. What’s New in the Treatment of Oral and Head and Neck Cancer
    5. Genomics and What’s New in the Treatment of Oral and Head and Neck Cancer
    6. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    7. Progress in the Treatment of Oral and Head and Neck Cancer

For Hodgkin Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. What’s New in the Treatment of Hodgkin Lymphoma
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Progress in the Treatment of Hodgkin Lymphoma
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. Update on CAR-T Cell Therapy for People Living with Lymphoma
    11. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    12. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    13. Update on CAR-T Cell Therapy
    14. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Progress in the Treatment of Hodgkin Lymphoma
    16. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Advances in Immunotherapy in the Treatment of Lymphoma

For Kidney Cancer

    1. Advances in the Treatment of Renal Cell Cancer

For Leukemia

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Living with Acute Myelogenous Leukemia (AML)
    3. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    4. Living with Chronic Myelogenous Leukemia (CML)
    5. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    10. Updates in the Treatment of Acute Myelogenous Leukemia
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia
    13. Medical Update on Acute Myelogenous Leukemia (AML)
    14. Update on Chronic Lymphocytic Leukemia
      Part I of Living with Chronic Lymphocytic Leukemia
    15. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    16. Older Persons Living with Chronic Lymphocytic Leukemia
    17. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    18. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    19. Managing Chronic Lymphocytic Leukemia and Its Complications
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    20. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    21. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    22. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    23. Medical Update on Acute Myelogenous Leukemia (AML)
    24. Update on Chronic Lymphocytic Leukemia (CLL)
    25. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    26. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Liver Cancer

    1. Treatment Update on Liver Cancer
    2. Treatment Update on Liver Cancer and Managing the Cost of Care
    3. Treatment Update on Liver Cancer and Managing the Cost of Care
    4. Treatment Update on Liver Cancer

For Lung Cancer

    1. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer
      Part II of Living with Lung Cancer
    2. Progress in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    3. Advances in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer
    4. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer During the Holidays
      Part II of Life with Lung Cancer
    5. Progress in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer
    6. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    7. What’s New in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    8. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer
      Part II of Living with Lung Cancer
    9. What’s New in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    10. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    11. Advances in the Treatment of Mesothelioma
    12. Advances in the Treatment of Lung Cancer
      Part I of Living With Lung Cancer
    13. Advances in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    14. Update on Small Cell Lung Cancer Treatments
      Part I of Living with Small Cell Lung Cancer

For Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in the Treatment of Hodgkin Lymphoma
    5. Treatment Update on Mantle Cell Lymphoma (MCL)
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    8. Taking Your Blood Cancer Treatment on Schedule
    9. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    10. Update on Diffuse Large B-Cell Lymphoma
    11. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Progress in the Treatment of Hodgkin Lymphoma
    14. Update on Cutaneous T-Cell Lymphoma
    15. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    16. Update on Diffuse Large B-Cell Lymphoma
    17. Treatment Update on Mantle Cell Lymphoma
    18. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    19. Progress in the Treatment of Follicular Lymphoma
    20. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    21. Update on Marginal Zone Lymphoma
    22. Update on CAR-T Cell Therapy for People Living with Lymphoma
    23. Update on Mantle Cell Lymphoma
    24. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    25. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    26. Treatment Update on Mantle Cell Lymphoma (MCL)
    27. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    28. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    29. Update on Marginal Zone Lymphoma
    30. Update on Cutaneous T-Cell Lymphoma
    31. Progress in the Treatment of Follicular Lymphoma
    32. Progress in the Treatment of Hodgkin Lymphoma
    33. Treatment Update on Mantle Cell Lymphoma (MCL)
    34. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    35. Advances in Immunotherapy in the Treatment of Lymphoma

For Mantle Cell Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Treatment Update on Mantle Cell Lymphoma (MCL)
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    9. Treatment Update on Mantle Cell Lymphoma
    10. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    11. Update on Mantle Cell Lymphoma
    12. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    13. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    14. Treatment Update on Mantle Cell Lymphoma (MCL)
    15. Update on CAR-T Cell Therapy
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Treatment Update on Mantle Cell Lymphoma (MCL)
    18. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    19. Advances in Immunotherapy in the Treatment of Lymphoma

For Marginal Zone Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on CAR-T Cell Therapy
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    8. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    9. Update on Marginal Zone Lymphoma
    10. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    11. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Update on Marginal Zone Lymphoma

For Melanoma

    1. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer
    2. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    3. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    5. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer

For Merkel Cell Carcinoma

    1. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)

For Mesothelioma

    1. Advances in the Treatment of Mesothelioma
    2. Advances in the Treatment of Mesothelioma

For Metastatic Breast Cancer

    1. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    2. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. What’s New in the Treatment of Breast Cancer for Women of All Ages
    6. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    7. The Latest Developments Reported at the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. What’s New in the Treatment of Metastatic Breast Cancer
    9. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    10. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    11. The Latest Developments Reported at the 41st Annual San Antonio Breast Cancer Symposium (SABCS)
    12. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    13. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer
      Part II of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    14. The Latest Developments Reported at the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    15. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    16. Advances in the Treatment of HER2 Positive Breast Cancer

For Multiple Myeloma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Progress in the Treatment of Multiple Myeloma
      Part I of Life with Multiple Myeloma
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Multiple Myeloma
    8. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Progress in the Treatment of Multiple Myeloma
    11. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Managing Symptoms and Treatment Side Effects of Multiple Myeloma
      Part III of Living with Multiple Myeloma

For Myelodysplastic Syndrome

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    3. Taking Your Blood Cancer Treatment on Schedule
    4. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    5. Progress in the Treatment of Myelodysplastic Syndromes (MDS)

For Myelofibrosis

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Taking Your Blood Cancer Treatment on Schedule
    4. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Myeloproliferative Neoplasms

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Taking Your Blood Cancer Treatment on Schedule
    4. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    7. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    8. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    9. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Non-Hodgkin Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on CAR-T Cell Therapy
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Update on Cutaneous T-Cell Lymphoma
    9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    10. Update on Diffuse Large B-Cell Lymphoma
    11. Treatment Update on Mantle Cell Lymphoma
    12. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    13. Progress in the Treatment of Follicular Lymphoma
    14. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    15. Update on Marginal Zone Lymphoma
    16. Update on CAR-T Cell Therapy for People Living with Lymphoma
    17. Update on Mantle Cell Lymphoma
    18. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    19. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    20. Treatment Update on Mantle Cell Lymphoma (MCL)
    21. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    22. Update on CAR-T Cell Therapy
    23. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    24. Update on Marginal Zone Lymphoma
    25. Update on Cutaneous T-Cell Lymphoma
    26. Progress in the Treatment of Follicular Lymphoma
    27. Treatment Update on Mantle Cell Lymphoma (MCL)
    28. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    29. Advances in Immunotherapy in the Treatment of Lymphoma

For Ovarian Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    2. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Medical Update on Ovarian Cancer
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Medical Update on Ovarian Cancer
    6. Update on Advanced Ovarian Cancer

For Pancreatic Cancer

    1. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part II of Your Guide to the Latest Cancer Research and Treatment
    2. Treatment Update on Pancreatic Cancer
    3. Update on the Treatment of Pancreatic Cancer
    4. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    5. Update on the Treatment of Pancreatic Cancer

For Peripheral T-Cell Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    3. Update on CAR-T Cell Therapy
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Taking Your Blood Cancer Treatment on Schedule
    6. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    9. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    10. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    11. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Advances in Immunotherapy in the Treatment of Lymphoma

For Polycythemia Vera

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Taking Your Blood Cancer Treatment on Schedule
    4. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    5. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    6. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    7. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    8. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Prostate Cancer

    1. Advances in the Treatment of Metastatic Prostate Cancer
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. For Caregivers: Coping with a Loved One’s Prostate Cancer
    5. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Your Guide to the Latest Cancer Research and Treatment
    6. Advances in the Treatment of Metastatic Prostate Cancer
      Part I of Living with Prostate Cancer

For Renal Cell Cancer

    1. Treatment Update on Renal Cell Cancer
    2. Advances in the Treatment of Renal Cell Cancer

For Sarcoma

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    2. Update on Soft Tissue Sarcoma
    3. Update on Rare Sarcomas
    4. Update on Soft Tissue Sarcoma
    5. Living with Gastrointestinal Stromal Tumors (GIST)

For Skin Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    4. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)
    5. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    6. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    7. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    8. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Small Lymphocytic Lymphoma

    1. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    2. Update on CAR-T Cell Therapy
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Taking Your Blood Cancer Treatment on Schedule
    5. Updates from the 2019 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    8. Updates from the 2018 American Society of Hematology (ASH) Annual Meeting
    9. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    10. Highlights from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Your Guide to the Latest Cancer Research and Treatment
    11. Update on CAR-T Cell Therapy
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Advances in Immunotherapy in the Treatment of Lymphoma

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Stomach Cancer

    1. Current Perspectives in the Treatment of Metastatic Gastric Cancer

For Thyroid Cancer

    1. Update on Thyroid Cancer

For Triple Negative Breast Cancer

    1. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    2. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. Triple Negative Breast Cancer and African American Women
    6. What’s New in the Treatment of Breast Cancer for Women of All Ages
    7. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    8. The Latest Developments Reported at the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer – Updates from the 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
    9. Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting: Caring for Every Patient, Learning from Every Patient
      Part I of Your Guide to the Latest Cancer Research and Treatment
    10. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    11. The Latest Developments Reported at the 41st Annual San Antonio Breast Cancer Symposium (SABCS)
    12. The Latest Developments Reported at the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Highlights from the 40th Annual San Antonio Breast Cancer Symposium (SABCS)
    13. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer

For Waldenstrom’s Macroglobulinemia

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    5. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.